Literature DB >> 3032339

Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain?

M D Majewska, R D Schwartz.   

Abstract

The interaction of the 'neurosteroid', pregnenolone-sulfate (PS), with the GABA/benzodiazepine/chloride ionophore receptor complex was investigated in rat brain subcellular preparations. At low micromolar concentrations PS competitively inhibited the binding of the convulsant [35S]t-butylbicyclophosphorothionate (TBPS) and antagonized pentobarbital-stimulated [3H]flunitrazepam binding to synaptosomes. In addition, PS inhibited muscimol-stimulated 36Cl-uptake in brain synaptoneurosomes, including that PS has characteristics of a relatively potent antagonist of the chloride channel coupled to the GABA receptor. Together with our previous finding that A-ring reduced metabolites of progesterone and deoxycorticosterone also interact with the GABA receptor complex but as hypnotic barbiturates, these data suggest that the regulation of GABAergic neurotransmission by various neurosteroids may be an important mechanism for controlling neuronal excitability.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032339     DOI: 10.1016/0006-8993(87)91394-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  52 in total

1.  Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis.

Authors:  Anny Sauvageau; Paul Desjardins; Violina Lozeva; Christopher Rose; Alan S Hazell; Alain Bouthillier; Roger F Butterwort
Journal:  Metab Brain Dis       Date:  2002-03       Impact factor: 3.584

Review 2.  Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?

Authors:  E A Jones; A S Basile
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

3.  Neurosteroids and self-reported pain in veterans who served in the U.S. Military after September 11, 2001.

Authors:  Jason D Kilts; Larry A Tupler; Francis J Keefe; Victoria M Payne; Robert M Hamer; Jennifer C Naylor; Rohana P Calnaido; Rajendra A Morey; Jennifer L Strauss; Gillian Parke; Mark W Massing; Nagy A Youssef; Lawrence J Shampine; Christine E Marx
Journal:  Pain Med       Date:  2010-08-23       Impact factor: 3.750

4.  Inhibition of the GABAA Receptor by Sulfated Neurosteroids: A Mechanistic Comparison Study between Pregnenolone Sulfate and Dehydroepiandrosterone Sulfate.

Authors:  Divya Sachidanandan; Amal Kanti Bera
Journal:  J Mol Neurosci       Date:  2015-03-01       Impact factor: 3.444

5.  The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.

Authors:  Kiran Sapkota; Kim Dore; Kang Tang; Mark Irvine; Guangyu Fang; Erica S Burnell; Roberto Malinow; David E Jane; Daniel T Monaghan
Journal:  Biochem Pharmacol       Date:  2018-11-29       Impact factor: 5.858

Review 6.  Neurosteroids: endogenous role in the human brain and therapeutic potentials.

Authors:  Doodipala Samba Reddy
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

7.  A post-training intrahippocampal anxiogenic dose of the neurosteroid pregnenolone sulfate impairs passive avoidance retention.

Authors:  E Martín-García; M Pallarés
Journal:  Exp Brain Res       Date:  2008-07-30       Impact factor: 1.972

Review 8.  The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

Authors:  W Hevers; H Lüddens
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

9.  Activation-dependent properties of pregnenolone sulfate inhibition of GABAA receptor-mediated current.

Authors:  Lawrence N Eisenman; Yejun He; Christopher Fields; Charles F Zorumski; Steven Mennerick
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

10.  Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors.

Authors:  Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  2007-10-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.